tirzepatide lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide Tops Semaglutide for Weight

As with all findings in this category, results are early-stage and not a basis for medical claims

So how are you achieving that [00:15:00] success with your patients

: , () ,

Beyond its primary indications for glycaemic control and weight loss, tirzepatide has demonstrated effects on several cardiovascular risk factors in clinical trials

Health Canada confirmed it is reviewing eight other generic semaglutide submissions and expects further decisions in the coming weeks and months [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]